Autoantibodies against myelin oligodendrocyte glycoprotein (MOG) are associated with autoimmune central nervous system diseases like acute disseminated encephalomyelitis (ADEM). For ADEM, it is speculated that a preceding infection is the trigger of the autoimmune response, but the mechanism connecting the infection to the production of MOG antibodies remains a mystery. We reasoned that the ability of B cells to capture cognate antigen from cell membranes, along with small quantities of coexpressed "bystander" antigens, might enable B-cell escape from tolerance. We tested this hypothesis using influenza hemagglutinin as a model viral antigen and transgenic, MOG-specific B cells. Using flow cytometry and live and fixed cell microscopy, we show that MOG-specific B cells take up large amounts of MOG from cell membranes. Uptake of the antigen from the membrane leads to a strong activation of the capturing B cell. When influenza hemagglutinin is also present in the membrane of the target cell, it can be cocaptured with MOG by MOG-specific B cells via the B-cell receptor. Hemagglutinin and MOG are both presented to T cells, which in turn are activated and proliferate. As a consequence, MOG-specific B cells get help from hemagglutinin-specific T cells to produce anti-MOG antibodies. In vivo, the transfer of MOG-specific B cells into recipient mice after the cocapture of MOG and hemagglutinin leads to the production of class-switched anti-MOG antibodies, dependent on the presence of hemagglutinin-specific T cells. This mechanism offers a link between infection and autoimmunity.
tolerance | autoantibodies | antigen capture | antigen presentation | influenza A n association between infections and autoimmunity has long been observed in clinical practice. Examples of this association are the onset of Guillain-Barré syndrome after intestinal Campylobacter infections and acute demyelinating encephalomyelitis (ADEM) following respiratory infections. Possible explanations for this connection between autoimmunity and infection include molecular mimicry between the infectious agent and the autoantigen and bystander activation of preexisting autoreactive immune cells. Although the molecular mimicry hypothesis is well supported for Guillain-Barré syndrome (1), the mechanisms leading to autoimmunity in other diseases are not understood. Among the most important suspected viral triggers of ADEM is influenza virus infection (2) . It is also known that pediatric patients with ADEM especially mount a humoral immune response against myelin oligodendrocyte glycoprotein (MOG) (3) . The mechnism through which the viral infection leads to the production of autoantibodies is unknown.
An important checkpoint for the avoidance of autoantibody production is the destruction of autoreactive B cells in the bone marrow (4) . Unlike the case of T-cell selection in the thymus, where the transcriptional regulator AIRE ensures the expression of otherwise tissue-specific antigens (5) , the set of antigens expressed in the bone marrow is limited, meaning that B cells whose Ig antigen receptors (B-cell receptor, BCR) recognize self-antigens restricted to other tissues can escape this selection and populate the periphery. Normally this does not lead to autoimmunity, because active production of antibodies requires T-cell help (6) . This takes place in secondary lymphoid organs and involves extensive physical contact with a helper T-cell whose antigen receptor (T-cell receptor, TCR) recognizes a peptide displayed on the B cell's major histocompatibility complex (MHC) class II molecules. Efficient negative T-cell selection in the thymus therefore also safeguards against the production of autoantibodies. If a B cell that recognizes a self-antigen is artificially enabled to obtain T-cell help, for example by immunization with the self-antigen covalently linked to an immunogenic foreign protein antigen, class-switched antibodies against the self-antigen can be produced (7) .
We hypothesized that breakdown of B-cell tolerance is initiated by the simultaneous uptake of an autoantigen and a viral antigen by B cells from infected parenchymal cells. Antigen capture from cell membranes differs significantly from capture of soluble antigen: Membrane-bound antigens are multivalent, increasing the binding avidity in comparison with a monovalent antigen in solution (8); moreover, membrane-bound antigens exist in association with other protein and lipid components of the membrane, so that sometimes these bystander molecules can be cocaptured with the cognate antigen (9) . We speculated that if such bystander antigens were processed and presented to T cells, it would circumvent the antigen specificity of T-cell help. Concretely, we hypothesize that if an autoreactive B cell binds a cognate self-antigen on the surface of a virus-infected cell, it can capture both self and neighboring viral antigens and, by presenting peptides from the viral antigen, can obtain T-cell help from antiviral T cells, leading to the production of antibodies against the self-antigen.
Significance
The immune system normally produces antibodies against pathogens and avoids making antibodies against self-proteins. In some individuals, antibodies against self-proteins (autoantibodies) are made and can cause debilitating disease, but the reasons for this failure of self-tolerance are not known. The experiments described test the following hypothesis linking viral infections and production of autoantibodies: A B cell whose immunoglobulin receptor recognizes a self-membrane protein can capture that protein from the membrane of a virus-infected cell and simultaneously cocapture viral proteins; fragments of the viral protein can then be presented to antiviral T cells and qualify for the positive signals for proliferation and antibody production known as T-cell help. We observed this phenomenon in vitro and in vivo.
We tested this hypothesis using adherent cells that express the CNS-restricted membrane protein MOG as a model self-antigen, influenza hemagglutinin (HA) as a model viral antigen, and transgenic mouse B and T cells specific for each antigen.
Results
Capture of Cognate Antigen from Membrane Is Rapid and Robust.
Capture of cognate antigen from membrane has been examined in molecular detail (10, 11) , generally using isolated membrane preparations. We examined the capture of cognate antigen from membranes of live cells by IgH MOG transgenic B cells, whose BCR recognizes the extracellular domain of MOG (12) . When IgH MOG B cells were exposed to adherent HEK cells that express a MOG-GFP fusion, GFP capture was detected in the B cells by flow cytometry as soon as 1 min after contact and continued to increase for more than 1 h (Fig. 1 A-C and Movie S1). Capture was paralleled by loss of surface IgM, indicating internalization of the BCR-antigen complex ( Fig. 1 A and B) . Immunolabeling of cocultures showed that captured antigen and IgM associate with LAMP1-immunoreactive structures within the B cell, presumably lysosomes ( Fig. 1 D and E) . Initially these structures are seen only at the interface of B cell and antigen-expressing HEK cell (Movie S2), but upon prolonged interaction, they distribute throughout the B cell ( Fig. 1 D and E and Movie S3). After extended interaction, the majority of the Ig colocalizes with antigen (Movie S3).
Membrane Antigen Capture Renders B Cells Highly Antigenic for T Cells.
We exposed IgH MOG B cells for 8, 12, or 20 h to adherent TE cells that express MOG (TE MOG) and examined expression of activation markers by flow cytometry. TE cells are more strongly adherent than HEK cells, facilitating their separation from B cells, but less efficiently transfected. In our hands, the type of antigenpresenting cell has no obvious influence on B-cell antigen capture. We compared these membrane antigen-capturing B cells with identical B cells exposed to non-antigen-expressing TE cells or to soluble MOG protein or to an IgM-crosslinking antibody. Loss of surface IgM was similar for B cells exposed to soluble or membrane-expressed antigen, but up-regulation of the activation markers CD69 and CD25 was far greater on the B cells exposed to membrane antigen ( Fig. 2A) . Up-regulation of class II MHC and CD86 was similar for the three kinds of BCR stimulation ( Fig. 2A) . Elevated class II expression was maintained longer after membrane capture than after other forms of BCR stimulation, but this effect was not statistically significant at the time points studied.
We (13) . The 2D2 T cells exposed to IgH MOG B cells after membrane capture proliferated more strongly than those cocultured with naive B cells in the presence of a high concentration of cognate peptide ( Fig. 2 B and C) . Soluble MOG protein was no more effective than peptide (Fig. 2C) . Neither B cells exposed to culture supernatants from antigen-expressing cells nor to TE cells that did not express antigen stimulated any proliferation. This rules out involvement of secreted soluble antigen or antigen-independent properties of the TE cells (Fig. 2C) . Rather, it appears that the act of antigen capture renders the capturing B cell highly stimulatory for T cells.
To test this interpretation, we assessed the stimulatory properties of B cells after membrane capture of antigens that were irrelevant for the responding T cell, with or without additional peptide that matches the T-cell specifitiy. We exposed HA-specific of exogenous MOG 35-55 peptide (Fig. 2D) . Without additional peptide, FluBI B cells stimulated no proliferation of 2D2 T cells, whether or not the B cells had previously encountered HA. With added peptide, even antigen-naive FluBI B cells stimulated T-cell proliferation but much less than B cells that had been previously activated by membrane HA capture (Fig. 2D) . The enhanced ability of B cells after membrane capture to stimulate T-cell proliferation may thus be due to the high level of activation of B cells and the concomitant increase in costimulatory ligands ( Fig. 2A) .
We also measured 2D2 T-cell proliferation in response to MOG-specific B cells exposed to the same TE cells with or without peptide (Fig. 2D) . Again, preexposure to membraneexpressed MOG rendered the B cells more stimulatory for the T cells than pulsing with peptide, whereas the presence of HA had no effect. Providing the antigen in a form recognizable by the BCR-that is, soluble MOG 1-125 protein-resulted in only slightly greater stimulation of T-cell proliferation than pulsing with MOG 35-55 peptide, and IgH MOG B cells were only slightly better in inducing 2D2 proliferation after capture of MOG 1-125 protein compared with FluBI B cells, which must take up the protein via a BCR-independent route. Most strikingly, FluBI cells exposed to TE cells that express both HA and MOG stimulated the proliferation of MOG-specific T cells, without the addition of exogenous MOG peptide. This implies that MOG had been cocaptured with HA and processed and presented.
Cocaptured, Noncognate Antigen Is Presented and Can Qualify B Cells for T-Cell Help. To visualize the capture of noncognate, "bystander" antigen, we generated an adherent HEK cell line stably cotransfected with MOG-GFP and HA (HEK HA MOG-GFP). We cocultured these cells with IgH MOG B cells or with FluBI B cells. Capture of MOG-GFP by IgH MOG B cells followed similar kinetics with or without coexpression of HA, but MOG-GFP capture by FluBI B cells was dependent on HA (Fig. 3A) . This bystander cocapture was as rapid as cognate capture, being observable after 3 min of contact, but quantitatively less. Not all antigens we examined were cocaptured. For example, when FluBI B cells were exposed to TE cells that express HA, MOG-GFP, and mOVA-Cherry, the MOG-GFP is cocaptured but the mOVA-cherry is not (Fig. 3B) . proliferation and activation were assessed by flow cytometry of Cell Trace Violet (CTV) dilution and CD25 immunofluorescence, respectively. The results from this model were consistent with the degree of cocapture observed previously. After exposure to TE MOG HA-OVA, IgH MOG B cells stimulated robust proliferation in OT-II T cells, and this was dependent on MOG (Fig. 4 A and B) . The increase in CD25 expression was not as great as in the cognate capture condition (Fig. 4A) , and the percentage of proliferated T cells was also lower (Fig. 4B) . We also saw secretion of IFN-γ, IL-2, and IL-4 in the interaction between B cells presenting a cocaptured antigen and T cells responding to that antigen, albeit less than in the cognate capture condition (Fig. 4C) . Presentation of the noncognate antigen is dependent on cocapture, because mOVA, which contains the OT-II epitope but is not cocaptured with HA or with MOG (Fig. 3B) , is also not presented to OT-II T cells by IgH MOG or FluBI B cells after exposure to TE MOG mOVA (Fig. 4D) . To be certain that this result was not due to inadequate expression of the mOVA protein at the cell membrane, we confirmed the accessibility of extracellular, membrane-bound OVA in live TE MOG mOVA cells (Fig. 4E) .
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To test whether cocaptured antigen would qualify B cells for T-cell help, we used the same combination of model antigensthat is, IgH MOG B cells capturing antigen from TE cells expressing both MOG and HA-OVA-but extended the subsequent coculture of IgH MOG B cells with OT-II T cells to 7 d. To exclude the involvement of BCR-independent antigen uptake and the possibility that the mere fact of capturing antigen stimulates antibody production, we included negative controls of IgH MOG B cells interacting with TE HA-OVA or with TE MOG HA. As a positive control, another cell line was established that stably expresses MOG fused to the OT-II OVA epitope (TE MOG-OVA). We exposed the IgH MOG B cells to the TE cells expressing the different antigen combinations, retrieved and cocultured them with OT-II T cells, and measured anti-MOG antibodies in the culture supernatants. Omitting the T cells, the OVA epitope, or MOG, no antibodies were detected.
When OT-II T cells were present and the OVA epitope was included in the B-cell cognate antigen, antibody production was robust. We clearly detected antibodies also when the OVA epitope was present on the HA antigen (Fig. 5A) . Autoreactive B cells that present cocaptured viral antigen can thus be triggered to produce autoantibodies by unrelated antiviral T cells. To test whether cocaptured antigen could mediate T-cell help in an in vivo setting, we exposed IgH MOG B cells to adherent cells expressing the same four combinations of antigens and adoptively transferred them into Rag −/− mice, together with OT-II T cells. Two weeks later, the mice were killed and anti-MOG antibodies in the serum were measured using an IgG2a-specific secondary antibody. Results mirrored those obtained in vitro: Antibodies were clearly produced in the cocapture condition (antigenic cells coexpressing MOG and HA-OVA)-at a lower level than in the cognate capture paradigm (cells expressing MOG-OVA) but well above the baseline level (Fig. 5B) . IgG2a production in the two negative control conditions (cells expressing either HA-OVA alone or MOG and HA) was not significantly different from baseline.
Discussion
Capture of antigen from membranes represents an alternative way of collecting antigen for B cells. It leads to strong activation of the B cell and robust antigen presentation. We show that membrane capture carries the risk that other antigens than the cognate one are cocaptured via the BCR, with two potentially pathological consequences: (i) Antiviral B cells acquire autoantigens together with the viral antigen and activate autoreactive T cells, and (ii) autoreactive B cells acquire viral antigens together with the autoantigen and get T-cell help from antiviral T cells to produce autoantibodies (Fig. 5C ). We provide evidence that both consequences can occur.
It is clear from our results that not all combinations of antigen, although present in the same membrane, will be cocaptured. The absence of significant cocapture of the membrane-OVA fusion protein indicates that the phenomenon does not involve wholesale capture of large fragments of membrane and is likely to be limited to a subset of protein antigens that either share some particular localization in the membrane or else have some direct interaction. One possibility, for example, is that the interaction we observe here depends on the interaction between sialic acid residues on the MOG protein and the sialic acid-binding domain of the HA (17). This would limit the phenomenon to the set of sialated proteins, which includes much but not all of the membrane proteome (18) . A major function of viral glycoproteins is attachment to host cell membranes, and therefore, the likelihood that viral proteins bind to the extracellular domains of membrane proteins is high. A limitation of our study is that antigen capture takes place in vitro. Experimentally, this enables us to control the coexpression of antigens, and to be sure that they are captured directly by B cells rather than by some third cell type, but begs the question of how and where B cells capture and cocapture antigen in vivo. A large body of work has demonstrated that soluble antigens and fluidborne viral particles are trapped and offered to B cells in the secondary lymphoid tissue by specialized cells including subcapsular macrophages and follicular dendritic cells (19) . However, we envisage that cocapture events relevant to autoimmunity are more likely to occur during direct capture of viral antigen from infected cells, which is likely to occur during the B-cell infiltration of infected tissues that is seen during the acute response to virus (20) .
The generation of autoantibodies via the cocapture mechanism is likely to be limited in several parameters. First, it will only occur during infections by viruses that encode abundant membrane proteins-that is, enveloped viruses. Second, autoantigens are limited to membrane proteins with an exposed extracellular domain. Third, the availability of nonanergised autoreactive B cells will be greatest for antigens that are not expressed in the bone marrow and particularly for antigens whose expression is limited to tissues that are not patrolled extensively by B cells under normal (i.e., noninflamed, noninfected) conditions, thereby avoiding the mechanisms of peripheral tolerance that are known to be triggered by exposure to selfantigen in the absence of cognate T-cell help (21) . These limitations might explain why this phenomenon rarely translates into the infection-associated autoimmunity seen in clinics. Nevertheless this mechanism represents an important deviation from a fundamental principle of immunology that has stood up well since its formulation in 1969: that antibody secretion by a B cell depends on an interaction with a T cell recognizing the same antigen (22) . We envisage that this and further study of the phenomenon will lead to significant modifications in the understanding of B-cell biology, autoimmunity, and tolerance.
Materials and Methods
Methods are described in detail in SI Materials and Methods. Cell lines are described in Table S1 , primary immune cells are described in Table S2 , and abbreviations used in the text are explained in Table S3 . ; also known as Th B cells) and C57BL/6-Tg(Tcra2D2,Tcrb2D2)1Kuch/J (2D2) mice (13) were bred from founder members provided by Guru Krishnamoorthy and Hartmut Wekerle, MaxPlanck-Institut für Neurobiologie, Martinsried, Germany. Primary immune cells were obtained from spleens by mechanical disruption and brief settlement to remove tissue fragments. B cells and CD4-positive T cells were obtained by negative selection using biotinylated antibodies and magnetic beads from Miltenyi. All procedures involving animals were considered and authorized by the Cantonal Tierversuchskommission.
Anti-MOG Antibody Assay. Anti-MOG antibodies were measured in sera and in culture supernatants by flow cytometry as previously described (3) . Supernatants were mixed with two volumes of reporter cell suspension in PBS containing 2% FCS by volume and 1 g/L of sodium azide on ice. The reporter cells include equal numbers of unlabeled TE MOG cells and CTV-labeled TE 0 cells. After 30 min on ice, the cells are washed, and antibodies adhering to the TE MOG cells are detected with Alexa 647 anti-mouse IgG or PerCP-conjugated anti-IgG2a secondary antibodies (both from Jackson Immunoresearch) and measured by flow cytometry. TE 0 and TE MOG populations are then separated by CTV label, and the ratio of geometric mean fluorescence intensities between TE MOG:TE 0 indicates the abundance of antibody in the supernatant.
Statistics. Geometric mean fluorescence intensities of activation markers on B cells were analyzed by two-way analysis of variance (time versus condition) and the effect of condition by one-way analysis of variance followed by Dunnett's Multiple Comparison Test to compare each of the conditions against "no stimulation." T-cell proliferation data (proportions of cells in the CTV-low gate) and anti-MOG Ig levels in sera were analyzed by one-way analysis of variance followed by Dunnett's test. Anti-MOG IgG levels in culture supernantants, expressed as ratios of geometric mean immunofluorescence TE MOG:TE 0, were analyzed by two-way analysis of variance (presence of T cells versus antigen condition), revealing a strong interaction, with an effect of condition limited to the T cells present condition. The Kruskal-Wallis test was therefore used to assess the effect of antigen condition, and Dunn's Multiple Comparison Test was used to compare each of the conditions with the T cells absent condition.
